SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/27/2019
Entire Document
 

Table of Contents
(continued)

 

Page

 

15.8   Agent in Individual Capacity 58
15.9   Successor Agent 59
15.10   Lender in Individual Capacity 59
15.11   Collateral Matters. 59
15.12   Restrictions on Actions by Lenders; Sharing of Payments 61
15.13   Agency for Perfection 61
15.14   Payments by Agent to the Lenders 61
15.15   Concerning the Collateral and Related Loan Documents 62
15.16   Confidentiality; Disclaimers by Lenders; Other Reports and Information 62
15.17   Several Obligations; No Liability 62
16.   WITHHOLDING TAXES 62
16.1   Payments 62
16.2   Exemptions 63
16.3   Reductions 63
16.4   Refunds 64
17.   GENERAL PROVISIONS 64
17.1   Effectiveness 64
17.2   Section Headings 64
17.3   Interpretation 64
17.4   Severability of Provisions 64
17.5   [Reserved] 64
17.6   Debtor-Creditor Relationship 65
17.7   Counterparts; Electronic Execution 65
17.8   Revival and Reinstatement of Obligations; Certain Waivers 65
17.9   Confidentiality 65
17.10   Survival 67
17.11   Patriot Act 67
17.12   Integration 67

 

 

 

 

-vi-